Collegium Pharmaceutical (COLL) Free Cash Flow (2014 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Free Cash Flow of $56.9 million for Q1 2026, up 4.22% year-over-year from $54.6 million in Q1 2025, and down 54.03% quarter-over-quarter from $123.8 million in Q4 2025.
Collegium Pharmaceutical (COLL) Free Cash Flow (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Free Cash Flow history runs 13 years deep, the most recent figure standing at $56.9 million for Q1 2026.
- In Q1 2026, Free Cash Flow rose 4.22% year-over-year to $56.9 million; the TTM figure through Mar 2026 stood at $331.3 million (up 67.31% YoY), while the FY2025 annual figure was $329.0 million, up 60.65% from the prior year.
- Free Cash Flow for Q1 2026 stood at $56.9 million, down from $123.8 million in the prior quarter.
- The five-year high for Free Cash Flow was $123.8 million in Q4 2025, with the low at -$25.4 million in Q1 2022.
- The 5-year median for Free Cash Flow is $65.4 million (2022), against an average of $58.1 million.
- The sharpest annual moves came in 2022 and 2025: Free Cash Flow tumbled 226.22% in 2022, then jumped 891.92% in 2025.
- Collegium Pharmaceutical's Free Cash Flow stood at $65.4 million in 2022, then climbed by 11.91% to $73.2 million in 2023, then gained by 16.9% to $85.5 million in 2024, then soared by 44.7% to $123.8 million in 2025, then tumbled by 54.03% to $56.9 million in 2026.
- Business Quant data shows COLL's Free Cash Flow at $56.9 million in Q1 2026, $123.8 million in Q4 2025, and $78.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Collegium Pharmaceutical | 894.62 Mn | 745.30 Mn | 110.29 Mn | 70.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 70.83 Mn |
| Jun 30, 2026 | 70.83 Mn |
| Mar 31, 2026 | 56.91 Mn |
| Mar 31, 2026 | 56.91 Mn |
| Dec 31, 2025 | 123.78 Mn |
| Dec 31, 2025 | 123.78 Mn |
| Sep 30, 2025 | 78.25 Mn |
| Sep 30, 2025 | 78.25 Mn |
| Jun 30, 2025 | 72.37 Mn |
| Jun 30, 2025 | 72.37 Mn |
| Mar 31, 2025 | 54.60 Mn |
| Mar 31, 2025 | 54.60 Mn |
| Dec 31, 2024 | 85.54 Mn |
| Dec 31, 2024 | 85.54 Mn |
| Sep 30, 2024 | -9.88 Mn |
| Sep 30, 2024 | -9.88 Mn |
| Jun 30, 2024 | 67.77 Mn |
| Jun 30, 2024 | 67.77 Mn |
| Mar 31, 2024 | 61.37 Mn |
| Mar 31, 2024 | 61.37 Mn |